menopause and glp 1 glp1 #womenshealth #perimenopause #menopause #healthdata #integrativehealth GLP-1 Therapies, Menopause, and Longevity:

Key takeaways What are GLP-1 medications

Due to their diverse structures, the pharmacokinetic profiles vary, and a prolonged half-life may be associated with an increased risk of adverse events

Ozempic is a diabetes drug, but it became a blockbuster in recent years when doctors and patients realized that people who took it lost significant weight

A retrospective cohort study based on administrative claims data of 32,800 exenatide patients who were propensity score matched to patients treated with MET or glyburide found no increased risk for either benign thyroid neoplasms (RR 0.7

7 For patients with type 2 diabetes who have atherosclerotic cardiovascular disease or are at high risk for it or who have kidney disease or heart failure, either a GLP-1 receptor agonist or an SGLT-2 inhibitor with demonstrated cardiovascular benefit with or without metformin is recommended, independent of the hemoglobin A1c level (level of evidence A)

They are verified to be free of bacterial contaminants, including endotoxins